"Atomic13 is focused on commercialising its ShAPE technology that manufactures high-quality aluminium extrusions from 100% post-consumer scrap, thereby reducing embodied carbon by 80-90%," Eric Donsky, Innovator, Chairman & CEO of Atomic13

Eric Donsky is a serial deep tech entrepreneur, having founded the first industrial synthetic biology and bio-based chemical company, which was spun out of 4 national labs funded by the U.S. DoE, including PNNL. This company went public on the NYSE at a $1B+ valuation. His latest venture, Atomic13, focuses on upcycling aluminium scrap into high-value aluminium extruded parts for the building and construction industry. The DoE has developed a highly novel solid-phase process technology that converts 100% post-consumer aluminium scrap into extruded parts that meet or exceed the ASTM standards on structural specifications for various aluminium alloys, including 6061 and 6063.

AL Circle: Give our readers a brief introduction about yourself and your startup, Atomic13.

Eric Donsky : I am a serial deep tech entrepreneur, having founded the first industrial synthetic biology and bio-based chemical company, which was spun out of 4 national labs funded by the U.S. DoE, including PNNL. This company went public on the NYSE at a $1B+ valuation. I also co-founded one of the earliest lab-on-a-chip diagnostic companies that matured into a $500M NASDAQ-listed company with global revenues.